Klik hier as dit jou persverklaring is!

Losartan Hoë Bloeddruk Medikasie Nou Herroep

Geskryf deur redakteur

Mint Pharmaceuticals Inc. herroep alle baie van sy voorskrif losartan tablette, in 50 mg en 100 mg sterkte, nadat toetse 'n azido onsuiwerheid gevind het (5-(4'-((5-(azidometiel)-2-butiel-4-chloor" -1H imidasool-1-yl)metiel)-[1,1'-bifeniel]-2-yl)-1H tetrasool) bo die aanvaarbare limiet. Langtermynblootstelling aan die onsuiwerheid op vlakke bo wat as veilig beskou word, kan moontlik die risiko van kanker verhoog.

Print Friendly, PDF & Email

Sien asseblief die volledige advies vir meer inligting, insluitend wat Kanadese moet doen en Health Canada se werk om die kwessie van azido-onsuiwerhede wat in sekere middels voorkom, aan te spreek.

ProdukmaatskappyDINLotVerval
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896572005006959April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896572005006960April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896572005006961April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896572005006962April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896572005006963April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896572005011154Junie 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896572005011156Junie 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896652005006807April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896652005006808April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896652005006809April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTEMint Pharmaceuticals Inc.023896652005006810April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETTE Mint Pharmaceuticals Inc.023896652105002149Desember 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896731805012687Oktober 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896731805012688Oktober 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896731805012689Oktober 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896731805012792Oktober 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896731905001010Desember 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTE Mint Pharmaceuticals Inc.023896731905001011Desember 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896732005006947April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896732005006949April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896732005006950April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896732005006951April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTE Mint Pharmaceuticals Inc.023896732005007297April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896732005007298April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896732005013776Augustus 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETTEMint Pharmaceuticals Inc.023896732105002150Desember 2023
Print Friendly, PDF & Email

Oor die skrywer

redakteur

Hoofredakteur is Linda Hohnholz.

Laat 'n boodskap